| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/10/2008 | US20080008713 Tumor Necrosis Factor Receptor I (TNFR1); immunoglobulins; competitive binding; inhibiting signal transduction; pharmacokinetics; storage stability |
| 01/10/2008 | US20080008712 Novel Phosphorylated Sequences of the Phosphatase Cdc25B, Antibodies for Said Sequences and Use Thereof |
| 01/10/2008 | US20080008711 Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers |
| 01/10/2008 | US20080008710 Therapeutic Agent And Diagnostic Agent For Cholangiocarcinoma |
| 01/10/2008 | US20080008709 Conjugation of biomolecules using Diels-Alder cycloaddition |
| 01/10/2008 | US20080008708 Tyrosine kinase inhibitors |
| 01/10/2008 | US20080008707 Denatured collagen peptides and uses thereof |
| 01/10/2008 | US20080008706 B7S1: an immune modulator |
| 01/10/2008 | US20080008705 Cancer prognostic diagnostic and treatment methods |
| 01/10/2008 | US20080008704 Methods of treating colorectal cancer with anti-epidermal growth factor antibodies |
| 01/10/2008 | US20080008703 Humanized Antibody Specific For Tumor Necrosis Factor-Alpha |
| 01/10/2008 | US20080008702 Antibody immunization therapy for treatment of atherosclerosis |
| 01/10/2008 | US20080008701 C-met receptor regulation by angiotensin iv (at4) receptor ligands |
| 01/10/2008 | US20080008700 Multimeric Fc Receptor Polypeptides |
| 01/10/2008 | US20080008699 Method for proteomic analysis utilizing immune recognition and cumulative subtraction |
| 01/10/2008 | US20080008694 Methods to prevent and treat diseases |
| 01/10/2008 | US20080008687 Transposon-Based Targeting System |
| 01/10/2008 | US20080008683 Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins |
| 01/10/2008 | US20080008682 Agonists; Treatment of Hepatitis C virus; combination with other drugs; phosphonate derivatives of purine or thiazolo(4,5-d)pyrimidine rings |
| 01/10/2008 | US20080008653 Models for vaccine assessment |
| 01/10/2008 | US20080008648 Treatment of Cancer With a Novel Anti-Il13 Monoclonal Antibody |
| 01/10/2008 | DE69133552C5 Deoxyribonucleic acid sequence encoding non-A, non-B hepatitis virus - obtd. Hutch C59 subgroup encoding polypeptide(s), useful as vaccines, and immuno reactive ABS for diagnosis of virus |
| 01/10/2008 | CA2697784A1 Novel regimens for treating diseases and disorders |
| 01/10/2008 | CA2692430A1 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 01/10/2008 | CA2692428A1 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 01/10/2008 | CA2691346A1 Dendritic cells generated using gm-csf and interferon alpha and loaded with heat-treated and killed cancer cells |
| 01/10/2008 | CA2656989A1 Methods to prevent and treat diseases |
| 01/10/2008 | CA2656771A1 Small streptococcus pyogenes antigens and their use |
| 01/10/2008 | CA2656756A1 Toxin detection method |
| 01/10/2008 | CA2656700A1 Compositions and methods for enhancing the efficacy of il-2 mediated immune responses |
| 01/10/2008 | CA2656620A1 Cd20 binding molecules for the treatment of copd |
| 01/10/2008 | CA2656613A1 Prevention of rash in patients undergoing anti-egfr therapy |
| 01/10/2008 | CA2656347A1 Composition for modulating the expression of cell adhesion molecules |
| 01/10/2008 | CA2652058A1 Compositions and methods for modulating immune responses |
| 01/09/2008 | EP1876241A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2008 | EP1876240A1 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876236A1 Antibody substituting for function of blood coagulation factor viii |
| 01/09/2008 | EP1876186A1 Prophylactic/therapeutic agent for cancer |
| 01/09/2008 | EP1875921A1 Dpp4 inhibitor and pharmaceutical application thereof |
| 01/09/2008 | EP1875250A2 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample |
| 01/09/2008 | EP1875247A2 Selective modulation of tumour necrosis factor receptors in therapy |
| 01/09/2008 | EP1875241A1 Metering technique for lateral flow assay devices |
| 01/09/2008 | EP1874923A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 01/09/2008 | EP1874918A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
| 01/09/2008 | EP1874824A2 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 01/09/2008 | EP1874821A1 Combination of antibodies and glucocorticoids for treating cancer |
| 01/09/2008 | EP1874820A2 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 01/09/2008 | EP1874816A2 Modulation of antibody effector function by hinge domain engineering |
| 01/09/2008 | EP1874810A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
| 01/09/2008 | EP1874806A2 Vaccine against burkholderia infections |
| 01/09/2008 | EP1874804A2 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 01/09/2008 | EP1874358A2 Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| 01/09/2008 | EP1874351A2 Anti-il-6 antibodies, compositions, methods and uses |
| 01/09/2008 | EP1874350A2 Method for treating dementia or alzheimer's disease with a cd20 antibody |
| 01/09/2008 | EP1874349A2 Use of cd25 antibodies in immunotherapy |
| 01/09/2008 | EP1874348A1 Immunomodulating compositions and uses therefor |
| 01/09/2008 | EP1874347A2 Composition and method for preventing or treating a virus infection |
| 01/09/2008 | EP1874346A1 Recombinant flavivirus vaccines |
| 01/09/2008 | EP1874345A2 Immunostimulatory compositions |
| 01/09/2008 | EP1874344A1 C. perfringens alpha toxoid vaccine |
| 01/09/2008 | EP1874343A2 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |
| 01/09/2008 | EP1874312A2 Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 01/09/2008 | EP1560848B1 Ptprk immunogenic peptide |
| 01/09/2008 | EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/09/2008 | EP1371664B1 Wti modified peptide |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1129196B1 Virulence genes and proteins, and their use |
| 01/09/2008 | EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/09/2008 | EP0917581B1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 01/09/2008 | EP0866726B2 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 01/09/2008 | EP0802979B1 Secreted viral cmv proteins useful for vaccines and diagnostics |
| 01/09/2008 | CN101103120A Methods for the production of ansamitocins |
| 01/09/2008 | CN101103103A Recombinant influenza vectors with tandem transcription units |
| 01/09/2008 | CN101103044A Anti-alhpha 9 integrin antibody and the use thereof |
| 01/09/2008 | CN101103043A Kir-binding agents and methods of use thereof |
| 01/09/2008 | CN101103042A IRTA-2 antibodies and their uses |
| 01/09/2008 | CN101102819A Prevention of thrombus formation and/or stabilization |
| 01/09/2008 | CN101102794A Compositions against sars-coronavirus and uses thereof |
| 01/09/2008 | CN101102793A Treatment method |
| 01/09/2008 | CN101102792A Treatment for multiple sclerosis |
| 01/09/2008 | CN101102791A Antibodies against vascular endothelial growth factor receptor-1 |
| 01/09/2008 | CN101102786A Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 01/09/2008 | CN101102733A Macromolecule-containing sustained release intraocular implants and related methods |
| 01/09/2008 | CN101100680A Recombination baculoviral for highly effectively expressing SARS coronavirus S protein and construction thereof |
| 01/09/2008 | CN101099865A A blocking monoclonal antibody to VLA-1 and its use for the treatment of vascular disorders |
| 01/09/2008 | CN101099864A Method for preparing inactivated vaccine both for preventing chicken Newcastle disease and infectious bronchitis |
| 01/09/2008 | CN101099863A Method for preparing triple inactivated vaccine for preventing chicken Newcastle disease, infectious bronchitis and egg drop syndrome |
| 01/09/2008 | CN101099862A Inactivated vaccine for preventing monkey from SV40 virus infection and preparation method |
| 01/09/2008 | CN100360668C Recombinant calmette-Guerin bacillus vaccine for secretion of tumour necrosis factor-alpha and its constructing method |
| 01/09/2008 | CN100360662C Preparation process and application of genetic engineering subunit vaccine of infectious bursal disease |
| 01/09/2008 | CN100360567C RS7 antibodies |
| 01/09/2008 | CN100360566C Pyloric bacillary spirillum resisting yolk immunoglobulin product and its application |
| 01/09/2008 | CN100360565C Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 01/09/2008 | CN100360558C Immunogenic compositions |
| 01/09/2008 | CN100360557C S protein of SARS virus, its vaccine and method for screening medicament using it |
| 01/09/2008 | CN100360556C Hepatitis B core antigen fusion proteins |
| 01/09/2008 | CN100360555C Immunological methods and compositions for the treatment of alzheimer's disease |
| 01/09/2008 | CN100360184C Stable isotonic lyophilized protein formulation |